Allelic specificity of Ube3a expression in the mouse brain during postnatal Development

Journal of Comparative Neurology

Volumn 522, Issue 8, 2014, Pages 1874-1896

  Judson, Matthew C ^a   Sosa Pagan, Jason O ^b   Del Cid, Wilmer A ^b   Han, Ji Eun ^a   Philpot, Benjamin D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Angelman syndrome; AS model mice; E6 AP; Epigenetic silencing; Genomic imprinting

Indexed keywords

PROTEIN UBE3A; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UBE3A PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ALLELE; ALLELIC SPECIFICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; BRAIN NERVE CELL; BREEDING; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; GENE AND NUCLEIC ACID PARAMETERS; GENE DELETION; GENE SILENCING; GENOTYPE; HISTOLOGY; MOUSE; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; CONGENIC STRAIN; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; MALE; MYELINATED NERVE; NEWBORN;

ALLELES; ANIMALS; ANIMALS, NEWBORN; BRAIN; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE FIBERS, MYELINATED; UBIQUITIN-PROTEIN LIGASES;

EID: 84897384178     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23507     Document Type: Article

References (84)

1. Albrecht U, Sutcliffe JS, Cattanach BM, Beechey CV, Armstrong D, Eichele G, Beaudet AL. 1997. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat Genet 17:75-78.
2. Altman J, Das GD. 1966. Autoradiographic and histological studies of postnatal neurogenesis. I. A longitudinal investigation of the kinetics, migration and transformation of cells incorporating tritiated thymidine in neonate rats, with special reference to postnatal neurogenesis in some brain regions. J Comp Neurol 126:337-389.
3. Angevine JB Jr, Sidman RL. 1961. Autoradiographic study of cell migration during histogenesis of cerebral cortex in the mouse. Nature 192:766-768.
4. Bandeira F, Lent R, Herculano-Houzel S. 2009. Changing numbers of neuronal and non-neuronal cells underlie postnatal brain growth in the rat. Proc Natl Acad Sci U S A 106:14108-14113.
5. Bayer SA, Altman J. 1975. The effects of X-irradiation on the postnatally-forming granule cell populations in the olfactory bulb, hippocampus, and cerebellum of the rat. Exp Neurol 48:167-174.
6. Bhat RV, Axt KJ, Fosnaugh JS, Smith KJ, Johnson KA, Hill DE, Kinzler KW, Baraban JM. 1996. Expression of the APC tumor suppressor protein in oligodendroglia. Glia 17:169-174.
7. Bower BD, Jeavons PM. 1967. The "happy puppet" syndrome. Arch Dis Child 42:298-302.
8. Cai J, Chen Y, Cai WH, Hurlock EC, Wu H, Kernie SG, Parada LF, Lu QR. 2007. A crucial role for Olig2 in white matter astrocyte development. Development 134:1887-1899.
9. Castro-Gago M, Gomez-Lado C, Eiris-Punal J, Rodriguez-Mugico VM. 2010. Abnormal myelination in Angelman syndrome. Eur J Paediatr Neurol 14:292.
10. Chun JJ, Shatz CJ. 1989. The earliest-generated neurons of the cat cerebral cortex: characterization by MAP2 and neurotransmitter immunohistochemistry during fetal life. J Neurosci 9:1648-1667.
11. Colas D, Wagstaff J, Fort P, Salvert D, Sarda N. 2005. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome. Neurobiol Dis 20:471-478.
12. Conant KD, Thibert RL, Thiele EA. 2009. Epilepsy and the sleep-wake patterns found in Angelman syndrome. Epilepsia 50:2497-2500.
13. Condon KH, Ho J, Robinson CG, Hanus C, Ehlers MD. 2013. The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation. J Neurosci 33:3799-3814.
14. Cooper EM, Hudson AW, Amos J, Wagstaff J, Howley PM. 2004. Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein. J Biol Chem 279:41208-41217.
15. Dimou L, Simon C, Kirchhoff F, Takebayashi H, Gotz M. 2008. Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. J Neurosci 28:10434-10442.
16. Dindot SV, Antalffy BA, Bhattacharjee MB, Beaudet AL. 2008. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet 17:111-118.
17. Eblen F, Graybiel AM. 1995. Highly restricted origin of prefrontal cortical inputs to striosomes in the macaque monkey. J Neurosci 15:5999-6013.
18. Egawa K, Kitagawa K, Inoue K, Takayama M, Takayama C, Saitoh S, Kishino T, Kitagawa M, Fukuda A. 2012. Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome. Sci Transl Med 4:163-157.
19. Encinas JM, Hamani C, Lozano AM, Enikolopov G. 2011. Neurogenic hippocampal targets of deep brain stimulation. J Comp Neurol 519:6-20.
20. Fishell G, van der Kooy D. 1987. Pattern formation in the striatum: developmental changes in the distribution of striatonigral neurons. J Neurosci 7:1969-1978.
21. Foster GA, Schultzberg M, Hokfelt T, Goldstein M, Hemmings HC Jr, Ouimet CC, Walaas SI, Greengard P. 1987. Development of a dopamine- and cyclic adenosine 3′:5′-monophosphate-regulated phosphoprotein (DARPP-32) in the prenatal rat central nervous system, and its relationship to the arrival of presumptive dopaminergic innervation. J Neurosci 7:1994-2018.
22. Gentile JK, Tan WH, Horowitz LT, Bacino CA, Skinner SA, Barbieri-Welge R, Bauer-Carlin A, Beaudet AL, Bichell TJ, Lee HS, Sahoo T, Waisbren SE, Bird LM, Peters SU. 2010. A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations. J Dev Behav Pediatr 31:592-601.
23. Gerfen CR. 1989. The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science 246:385-388.
24. Greer PL, Hanayama R, Bloodgood BL, Mardinly AR, Lipton DM, Flavell SW, Kim TK, Griffith EC, Waldon Z, Maehr R, Ploegh HL, Chowdhury S, Worley PF, Steen J, Greenberg ME. 2010. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140:704-716.
25. Gustin RM, Bichell TJ, Bubser M, Daily J, Filonova I, Mrelashvili D, Deutch AY, Colbran RJ, Weeber EJ, Haas KF. 2010. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome. Neurobiol Dis 39:283-291.
26. Hanbury R, Ling ZD, Wuu J, Kordower JH. 2003. GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults. J Comp Neurol 461:307-316.
27. Harting I, Seitz A, Rating D, Sartor K, Zschocke J, Janssen B, Ebinger F, Wolf NI. 2009. Abnormal myelination in Angelman syndrome. Eur J Paediatr Neurol 13:271-276.
28. Heck DH, Zhao Y, Roy S, LeDoux MS, Reiter LT. 2008. Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors. Hum Mol Genet 17:2181-2189.
29. Herzing LB, Cook EH, Jr., Ledbetter DH. 2002. Allele-specific expression analysis by RNA-FISH demonstrates preferential maternal expression of UBE3A and imprint maintenance within 15q11- q13 duplications. Hum Mol Genet 11:1707-1718.
30. Hoerder-Suabedissen A, Molnar Z. 2013. Molecular diversity of early-born subplate neurons. Cerebr Cortex 23:1473-1483.
31. Huang HS, Allen JA, Mabb AM, King IF, Miriyala J, Taylor-Blake B, Sciaky N, Dutton JW Jr, Lee HM, Chen X, Jin J, Bridges AS, Zylka MJ, Roth BL, Philpot BD. 2012. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature 481:185-189.
32. Jiang YH, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G, Sweatt JD, Beaudet AL. 1998. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21:799-811.
33. Jones LG, Prins J, Park S, Walton JP, Luebke AE, Lurie DI. 2008. Lead exposure during development results in increased neurofilament phosphorylation, neuritic beading, and temporal processing deficits within the murine auditory brainstem. J Comp Neurol 506:1003-1017.
34. Kanold PO, Luhmann HJ. 2010. The subplate and early cortical circuits. Annu Rev Neurosci 33:23-48.
35. Kao HT, Li P, Chao HM, Janoschka S, Pham K, Feng J, McEwen BS, Greengard P, Pieribone VA, Porton B. 2008. Early involvement of synapsin III in neural progenitor cell development in the adult hippocampus. J Comp Neurol 507:1860-1870.
36. Kaphzan H, Buffington SA, Jung JI, Rasband MN, Klann E. 2011. Alterations in intrinsic membrane properties and the axon initial segment in a mouse model of Angelman syndrome. J Neurosci 31:17637-17648.
37. Kishino T, Lalande M, Wagstaff J. 1997. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 15:70-73.
38. Komuro H, Rakic P. 1998. Distinct modes of neuronal migration in different domains of developing cerebellar cortex. J Neurosci 18:1478-1490.
39. Kostovic I, Rakic P. 1980. Cytology and time of origin of interstitial neurons in the white matter in infant and adult human and monkey telencephalon. J Neurocytol 9:219-242.
40. Lalande M, Calciano MA. 2007. Molecular epigenetics of Angelman syndrome. Cell Mol Life Sci 64:947-960.
41. Landers M, Bancescu DL, Le Meur E, Rougeulle C, Glatt-Deeley H, Brannan C, Muscatelli F, Lalande M. 2004. Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn. Nucleic Acids Res 32:3480-3492.
42. Leung KN, Vallero RO, DuBose AJ, Resnick JL, LaSalle JM. 2009. Imprinting regulates mammalian snoRNA-encoding chromatin decondensation and neuronal nucleolar size. Hum Mol Genet 18:4227-4238.
43. Leung KN, Chamberlain SJ, Lalande M, LaSalle JM. 2011. Neuronal chromatin dynamics of imprinting in development and disease. J Cell Biochem 112:365-373.
44. Lossie AC, Whitney MM, Amidon D, Dong HJ, Chen P, Theriaque D, Hutson A, Nicholls RD, Zori RT, Williams CA, Driscoll DJ. 2001. Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet 38:834-845.
45. Mabb AM, Judson MC, Zylka MJ, Philpot BD. 2011. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci 34:293-303.
46. Mardirossian S, Rampon C, Salvert D, Fort P, Sarda N. 2009. Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome. Exp Neurol 220:341-348.
47. Martinez-Noel G, Galligan JT, Sowa ME, Arndt V, Overton TM, Harper JW, Howley PM. 2012. Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes. Mol Cell Biol 32:3095-3106.
48. Mathews EA, Morgenstern NA, Piatti VC, Zhao C, Jessberger S, Schinder AF, Gage FH. 2010. A distinctive layering pattern of mouse dentate granule cells is generated by developmental and adult neurogenesis. J Comp Neurol 518:4479-4490.
49. Matsuura T, Sutcliffe JS, Fang P, Galjaard RJ, Jiang YH, Benton CS, Rommens JM, Beaudet AL. 1997. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 15:74-77.
50. Meng L, Person RE, Beaudet AL. 2012. Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a. Hum Mol Genet 21:3001-3012.
51. Miano S, Bruni O, Leuzzi V, Elia M, Verrillo E, Ferri R. 2004. Sleep polygraphy in Angelman syndrome. Clin Neurophysiol 115:938-945.
52. Miao S, Chen R, Ye J, Tan GH, Li S, Zhang J, Jiang YH, Xiong ZQ. 2013. The Angelman syndrome protein Ube3a is required for polarized dendrite morphogenesis in pyramidal neurons. J Neurosci 33:327-333.
53. Miura K, Kishino T, Li E, Webber H, Dikkes P, Holmes GL, Wagstaff J. 2002. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobiol Dis 9:149-159.
54. Moncla A, Malzac P, Voelckel MA, Auquier P, Girardot L, Mattei MG, Philip N, Mattei JF, Lalande M, Livet MO. 1999. Phenotype-genotype correlation in 20 deletion and 20 non-deletion Angelman syndrome patients. Eur J Hum Genet 7:131-139.
55. Mulherkar SA, Jana NR. 2010. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome. Neurobiol Dis 40:586-592.
56. Nicholls RD, Knepper JL. 2001. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet 2:153-175.
57. Numata K, Kohama C, Abe K, Kiyosawa H. 2011. Highly parallel SNP genotyping reveals high-resolution landscape of mono-allelic Ube3a expression associated with locus-wide antisense transcription. Nucleic Acids Res 39:2649-2657.
58. Pelc K, Boyd SG, Cheron G, Dan B. 2008. Epilepsy in Angelman syndrome. Seizure 17:211-217.
59. Peters SU, Beaudet AL, Madduri N, Bacino CA. 2004. Autism in Angelman syndrome: implications for autism research. Clin Genet 66:530-536.
60. Peters SU, Kaufmann WE, Bacino CA, Anderson AW, Adapa P, Chu Z, Yallampalli R, Traipe E, Hunter JV, Wilde EA. 2011. Alterations in white matter pathways in Angelman syndrome. Dev Med Child Neurol 53:361-367.
61. Price DJ, Aslam S, Tasker L, Gillies K. 1997. Fates of the earliest generated cells in the developing murine neocortex. J Comp Neurol 377414-422.
62. Rakic P. 1974. Neurons in rhesus monkey visual cortex: systematic relation between time of origin and eventual disposition. Science 183:425-427.
63. Reim K, Regus-Leidig H, Ammermuller J, El-Kordi A, Radyushkin K, Ehrenreich H, Brandstatter JH, Brose N. 2009. Aberrant function and structure of retinal ribbon synapses in the absence of complexin 3 and complexin 4. J Cell Sci 122:1352-1361.
64. Riday TT, Dankoski EC, Krouse MC, Fish EW, Walsh PL, Han JE, Hodge CW, Wightman RM, Philpot BD, Malanga CJ. 2012. Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome. J Clin Invest 122:4544-4554.
65. Sahay A, Scobie KN, Hill AS, O'Carroll CM, Kheirbek MA, Burghardt NS, Fenton AA, Dranovsky A, Hen R. 2011. Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature 472:466-470.
66. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R. 2003. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805-809.
67. Sato M, Stryker MP. 2010. Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a. Proc Natl Acad Sci U S A 107:5611-5616.
68. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
69. Schlessinger AR, Cowan WM, Gottlieb DI. 1975. An autoradiographic study of the time of origin and the pattern of granule cell migration in the dentate gyrus of the rat. J Comp Neurol 159:149-175.
70. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671-675.
71. Sutcliffe JS, Nakao M, Christian S, Orstavik KH, Tommerup N, Ledbetter DH, Beaudet AL. 1994. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat Genet 8:52-58.
72. Sutcliffe JS, Jiang YH, Galijaard RJ, Matsuura T, Fang P, Kubota T, Christian SL, Bressler J, Cattanach B, Ledbetter DH, Beaudet AL. 1997. The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region. Genome Res 7:368-377.
73. Thibert RL, Larson AM, Hsieh DT, Raby AR, Thiele EA. 2013. Neurologic manifestations of angelman syndrome. Pediatr Neurol 48:271-279.
74. Tiwari VN, Jeong JW, Wilson BJ, Behen ME, Chugani HT, Sundaram SK. 2012. Relationship between aberrant brain connectivity and clinical features in Angelman syndrome: a new method using tract based spatial statistics of DTI color-coded orientation maps. NeuroImage 59:349-355.
75. Tripathi RB, McTigue DM. 2008. Chronically increased ciliary neurotrophic factor and fibroblast growth factor-2 expression after spinal contusion in rats. J Comp Neurol 510:129-144.
76. Tseng YY, Gruzdeva N, Li A, Chuang JZ, Sung CH. 2010. Identification of the Tctex-1 regulatory element that directs expression to neural stem/progenitor cells in developing and adult brain. J Comp Neurol 518:3327-3342.
77. van der Kooy D, Fishell G. 1987. Neuronal birthdate underlies the development of striatal compartments. Brain Res 401:155-161.
78. Vincze A, Mazlo M, Seress L, Komoly S, Abraham H. 2008. A correlative light and electron microscopic study of postnatal myelination in the murine corpus callosum. Int J Dev Neurosci 26:575-584.
79. Wallace ML, Burette AC, Weinberg RJ, Philpot BD. 2012. Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. Neuron 74:793-800.
80. Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, Magenis RE, Moncla A, Schinzel AA, Summers JA, Wagstaff J. 2006. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A 140:413-418.
81. Williams CA, Driscoll DJ, Dagli AI. 2010. Clinical and genetic aspects of Angelman syndrome. Genet Med 12:385-395.
82. Xu X, Roby KD, Callaway EM. 2006. Mouse cortical inhibitory neuron type that coexpresses somatostatin and calretinin. J Comp Neurol 499:144-160.
83. Yamamoto Y, Huibregtse JM, Howley PM. 1997. The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing. Genomics 41:263-266.
84. Yamasaki K. 2003. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum Mol Genet 12:837-847.